AWM
CYCN icon

Activest Wealth Management’s Cyclerion Therapeutics CYCN Stock Holding History

Activest Wealth Management’s Portfolio CYCN Stock Details CYCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$339 Hold
100
– – ﹤0.01% 1106
2026
Q1 		$155 Hold
100
– – ﹤0.01% 1132
2025
Q4 		$127 Hold
100
– – ﹤0.01% 1057
2025
Q3 		$230 Hold
100
– – ﹤0.01% 1012
2025
Q2 		$291 Hold
100
– – ﹤0.01% 936
2025
Q1 		$250 Hold
100
– – ﹤0.01% 921
2024
Q4 		$322 Hold
100
– – ﹤0.01% 584
2024
Q3 		$259 Hold
100
– – ﹤0.01% 510
2024
Q2 		$230 Buy
+100
New +$284 ﹤0.01% 485

Activest Wealth Management's CYCN Position: Q2 2026 in Review

Activest Wealth Management held its Cyclerion Therapeutics (CYCN) position steady in Q2 2026 at 100 shares worth $339. The position accounts for ﹤0.01% of the portfolio, ranked #1106.

Activest Wealth Management first reported a position in CYCN in Q2 2024 and has held it in 9 quarters since. 1 fund tracked by Wall St. Rank holds CYCN as of Q2 2026.

  • Activest Wealth Management held 100 shares of Cyclerion Therapeutics worth $339 as of Q2 2026.
  • Activest Wealth Management left its Cyclerion Therapeutics share count unchanged in Q2 2026.
  • Cyclerion Therapeutics made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #1106 holding.
  • Activest Wealth Management first reported a position in Cyclerion Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 1 fund tracked by Wall St. Rank held Cyclerion Therapeutics as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.